Skip to main content

Emerging Therapies

Emerging Therapies
Selective, Small-Molecule DRD2 Antagonist Induces Tumor Regression in Recurrent High-Grade Glioma
Read More
Emerging Therapies
Autologous Mesothelin-Targeted T-Cells Induce Responses in Pleural Solid Tumors
Wayne Kuznar
Read More
Emerging Therapies
Dual-Specific CAR T-Cell Therapy Targets CD19 and CD22 in Patients with Acute Lymphoblastic Leukemia
Chase Doyle
Read More
Emerging Therapies
AMG 420, a Novel BiTE, Shows Impressive Responses in Heavily Treated Patients with Multiple Myeloma
Wayne Kuznar
Read More
Emerging Therapies
Selinexor a Promising Oral Option in Triple-Class Refractory Multiple Myeloma
Wayne Kuznar
Read More
Emerging Therapies
Ivosidenib a New Standard of Care for Relapsed or Refractory AML with IDH1 Mutation
Read More
Emerging Therapies
LOXO-292 Highly Effective in RET-Positive Cancers
Read More
Emerging Therapies
Novel Assay Provides 100 Times More Information Than Current Liquid Biopsies for Early Cancer Detection
Read More
Emerging Therapies
Cediranib-Based Combination Therapy Extends Progression-Free Survival in Relapsed Ovarian Cancer
Read More
Emerging Therapies
Dacomitinib Represents Potential New Targeted Therapy for EGFR Mutation–Positive Lung Cancer
Read More
Page 2 of 7
Results 11 - 20 of 67